Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  July 2014  »
MonTueWedThuFriSatSun
 123456
78910111213
14151617181920
21222324252627
28293031 

Friends
    Links


    Entry 1 of 3073
    Last Page | Next Page
    1/28/2010 - ResearchPoint & Azaya Therapeutics Announce First Patient Enrolled In Phase I Clinical Study
    Posted in Medical News

    ResearchPoint and Azaya Therapeutics, Inc. are proud to promulgate the study initiation and enrollment of the first patient in the phase I clinical study of ATI-1123, a new formulation of docetaxel. ATI-1123 has the same active element as the FDA approved drug Taxotere® (docetaxel). The study is being conducted at two premier Texas cancer centers in clients with precocious solid tumors. The open-label, dose jump study is being managed by ResearchPoint, a leading Texas-based CRO with wide-ranging oncology trial experience...



    More: - Brought to my attention by

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio